These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


431 related items for PubMed ID: 3335031

  • 41. Regional measurements of blood-to-tissue transport in experimental RG-2 rat gliomas.
    Groothuis DR, Fischer JM, Pasternak JF, Blasberg RG, Vick NA, Bigner DD.
    Cancer Res; 1983 Jul; 43(7):3368-73. PubMed ID: 6850641
    [Abstract] [Full Text] [Related]

  • 42. The effects of pentobarbital on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
    Chi OZ, Chun TW, Liu X, Weiss HR.
    Anesth Analg; 1998 Jun; 86(6):1230-5. PubMed ID: 9620510
    [Abstract] [Full Text] [Related]

  • 43. [Intra-arterial chemotherapy of malignant glioma after osmotic blood-brain barrier disruption].
    Yamada K, Takahama H, Nakai O, Takanashi T, Hosoya T.
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2692-6. PubMed ID: 2506817
    [Abstract] [Full Text] [Related]

  • 44. Osmotic opening of the blood-brain barrier to methotrexate in the rat.
    Ohno K, Fredericks WR, Rapoport SI.
    Surg Neurol; 1979 Oct; 12(4):323-8. PubMed ID: 524251
    [Abstract] [Full Text] [Related]

  • 45. Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier.
    Neuwelt EA, Frenkel EP, D'Agostino AN, Carney DN, Minna JD, Barnett PA, McCormick CI.
    Cancer Res; 1985 Jun; 45(6):2827-33. PubMed ID: 2985254
    [Abstract] [Full Text] [Related]

  • 46. [Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas].
    Heimberger K, Samec P, Podreka I, Binder H, Suess E, Reisner T, Deecke L, Steger G, Hiesmayr M, Dittrich C.
    Wien Klin Wochenschr; 1987 May 29; 99(11):385-8. PubMed ID: 3113082
    [Abstract] [Full Text] [Related]

  • 47. Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors.
    Inamura T, Nomura T, Bartus RT, Black KL.
    J Neurosurg; 1994 Nov 29; 81(5):752-8. PubMed ID: 7931623
    [Abstract] [Full Text] [Related]

  • 48. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors.
    Nomura T, Inamura T, Black KL.
    Brain Res; 1994 Oct 03; 659(1-2):62-6. PubMed ID: 7529648
    [Abstract] [Full Text] [Related]

  • 49. Dexamethasone effects on [125I]albumin distribution in experimental RG-2 gliomas and adjacent brain.
    Nakagawa H, Groothuis DR, Owens ES, Fenstermacher JD, Patlak CS, Blasberg RG.
    J Cereb Blood Flow Metab; 1987 Dec 03; 7(6):687-701. PubMed ID: 3693426
    [Abstract] [Full Text] [Related]

  • 50. Selective blood-tumor barrier disruption by leukotrienes.
    Chio CC, Baba T, Black KL.
    J Neurosurg; 1992 Sep 03; 77(3):407-10. PubMed ID: 1506887
    [Abstract] [Full Text] [Related]

  • 51. [Distribution of cis-diamminedichloroplatinum in patients with metastatic brain tumors after intravenous or intracarotid administration].
    Nakagawa H, Fujita T, Izumoto S, Kubo S, Nakajima Y, Turuzono K.
    Gan To Kagaku Ryoho; 1991 Jan 03; 18(1):103-9. PubMed ID: 1987891
    [Abstract] [Full Text] [Related]

  • 52. [Distribution and acute toxicity of a new morpholinoanthracycline, MX2, in normal rat brain after intra-arterial injection].
    Izumoto S, Arita N, Hayakawa T, Ohnishi T, Hiraga S, Taki T, Yamamoto H.
    Gan To Kagaku Ryoho; 1991 Mar 03; 18(3):371-5. PubMed ID: 2003739
    [Abstract] [Full Text] [Related]

  • 53. Relationship between drug delivery and the intra-arterial infusion rate of SarCNU in C6 rat brain tumor model.
    Takeda N, Diksic M.
    J Neurooncol; 1999 Feb 03; 41(3):235-46. PubMed ID: 10359143
    [Abstract] [Full Text] [Related]

  • 54. Model for drug uptake by brain tumors: effects of osmotic treatment and of diffusion in brain.
    Robinson PJ, Rapoport SI.
    J Cereb Blood Flow Metab; 1990 Mar 03; 10(2):153-61. PubMed ID: 2303532
    [Abstract] [Full Text] [Related]

  • 55. [Blood-brain barrier opening microcirculation in human brain tumor].
    Sato S, Toya S, Otani M.
    No To Shinkei; 1985 Feb 03; 37(2):109-13. PubMed ID: 2988587
    [Abstract] [Full Text] [Related]

  • 56. The pharmacology of diaziquone given in intravenous or intracarotid infusion to normal and intracranial tumor-bearing puppies.
    Egorin MJ, Bellis EH, Salcman M, Collins JM, Spiegel JF, Bachur NR.
    J Neurosurg; 1984 May 03; 60(5):1005-13. PubMed ID: 6716135
    [Abstract] [Full Text] [Related]

  • 57. Concurrent measurements of blood flow and transcapillary transport in xenotransplanted human gliomas in immunosuppressed rats.
    Vriesendorp FJ, Peagram C, Bigner DD, Groothuis DR.
    J Natl Cancer Inst; 1987 Jul 03; 79(1):123-30. PubMed ID: 3474439
    [Abstract] [Full Text] [Related]

  • 58. Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas.
    Weyerbrock A, Walbridge S, Pluta RM, Saavedra JE, Keefer LK, Oldfield EH.
    J Neurosurg; 2003 Oct 03; 99(4):728-37. PubMed ID: 14567609
    [Abstract] [Full Text] [Related]

  • 59. Tissue distribution of methotrexate following administration as a solution and as a magnetic microsphere conjugate in rats bearing brain tumors.
    Devineni D, Klein-Szanto A, Gallo JM.
    J Neurooncol; 1995 Oct 03; 24(2):143-52. PubMed ID: 7562001
    [Abstract] [Full Text] [Related]

  • 60. Transnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapy.
    Shingaki T, Inoue D, Furubayashi T, Sakane T, Katsumi H, Yamamoto A, Yamashita S.
    Mol Pharm; 2010 Oct 04; 7(5):1561-8. PubMed ID: 20695463
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.